RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Perrigo Company Stock

Perrigo Company ROE 2024

Perrigo Company ROE

-0

Ticker

PRGO

ISIN

IE00BGH1M568

WKN

A1XAEY

In 2024, Perrigo Company's return on equity (ROE) was -0, a -90.83% increase from the -0.03 ROE in the previous year.

Perrigo Company Aktienanalyse

What does Perrigo Company do?

The Perrigo Company PLC is a globally operating company in the pharmaceutical and healthcare products sector. The company was founded in 1887 as The Donerail Corporation and is headquartered in Dublin, Ireland. Perrigo's business model focuses on healthcare products and offers a wide range of products, ranging from over-the-counter medications to dietary supplements and personal care products. The company is divided into three business segments: Consumer Healthcare Americas, serving the markets in North, Central, and South America; Consumer Healthcare International, serving the markets in Europe, Australasia, Asia, and Israel; and Pharmaceutical, which includes pharmaceutical manufacturing and development. The Consumer Healthcare Americas segment focuses on developing products that aid in the treatment and prevention of various health issues. Some of the well-known products include the dietary supplement brand Emergen-C, the allergy and sinus product brand GoodSense, and the pain relief brand TopCare. Consumer Healthcare International offers similar products to the Consumer Healthcare Americas segment, but with a focus on the international market. The product range includes pain relief, cold and flu products, skincare products, vitamins and minerals, oral care products, and household products. The Pharmaceutical segment specializes in the manufacturing and development of generic drugs, biosimilars, and over-the-counter medications. The company has extensive experience in generics manufacturing and has recently expanded its product portfolio to include biologics and pharmaceutical development. Perrigo's pharmaceutical products are widely recognized and sold in many countries. Some of the well-known products include the blockbuster injectable methotrexate Heumann, a highly effective immunosuppressant used in the treatment of autoimmune diseases. Perrigo is a leading provider of quality products and continuously develops new products to meet the needs of its customers. The company places a high value on research and development and works closely with professionals in the medical field. Perrigo has established an extensive global distribution network to ensure its products are available worldwide. In recent years, the company has strengthened its market presence through mergers and acquisitions. In 2015, Perrigo acquired Irish pharmaceutical company Elan Corporation, which specializes in the development of drugs for neurodegenerative diseases. This acquisition expanded Perrigo's product portfolio in biologics development. Since 2019, Ranir, a global leader in oral care products, has also been integrated into the company. In the recent past, Perrigo has set a target date by which it aims to resolve tax issues related to a series of disputed transactions with the IRS. The target is the end of June 2021, by which the company aims to achieve a satisfactory outcome and move forward. Overall, Perrigo has a successful history as a leading provider of pharmaceutical and healthcare products. The company is able to meet the needs of its customers worldwide by offering a wide range of products, from over-the-counter medications to dietary supplements and personal care products. With a strong focus on research and development, Perrigo has strengthened its market presence through mergers and acquisitions in recent years, promising a bright future for the company. Perrigo Company ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Perrigo Company's Return on Equity (ROE)

Perrigo Company's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Perrigo Company's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Perrigo Company's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Perrigo Company’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Perrigo Company stock

What is the ROE (Return on Equity) of Perrigo Company this year?

The ROE of Perrigo Company this year is -0 undefined.

How has the Return on Equity (ROE) of Perrigo Company developed compared to the previous year?

The ROE of Perrigo Company has increased by -90.83% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Perrigo Company?

A high ROE indicates that Perrigo Company generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Perrigo Company?

A low ROE can indicate that Perrigo Company is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Perrigo Company affect the company?

A change in ROE (Return on Equity) of Perrigo Company can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Perrigo Company?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Perrigo Company?

Some factors that can influence Perrigo Company's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Perrigo Company pay?

Over the past 12 months, Perrigo Company paid a dividend of 1.09 USD . This corresponds to a dividend yield of about 3.86 %. For the coming 12 months, Perrigo Company is expected to pay a dividend of 1.08 USD.

What is the dividend yield of Perrigo Company?

The current dividend yield of Perrigo Company is 3.86 %.

When does Perrigo Company pay dividends?

Perrigo Company pays a quarterly dividend. This is distributed in the months of September, December, April, June.

How secure is the dividend of Perrigo Company?

Perrigo Company paid dividends every year for the past 25 years.

What is the dividend of Perrigo Company?

For the upcoming 12 months, dividends amounting to 1.08 USD are expected. This corresponds to a dividend yield of 3.84 %.

In which sector is Perrigo Company located?

Perrigo Company is assigned to the 'Health' sector.

Wann musste ich die Aktien von Perrigo Company kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Perrigo Company from 6/18/2024 amounting to 0.276 USD, you needed to have the stock in your portfolio before the ex-date on 5/31/2024.

When did Perrigo Company pay the last dividend?

The last dividend was paid out on 6/18/2024.

What was the dividend of Perrigo Company in the year 2023?

In the year 2023, Perrigo Company distributed 1.04 USD as dividends.

In which currency does Perrigo Company pay out the dividend?

The dividends of Perrigo Company are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Perrigo Company

Our stock analysis for Perrigo Company Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Perrigo Company Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.